» Investing in biotech – an article series
» Spago Nanomedical in hot area
» Idogen's acting CEO talks about plans for the fall
» Emplicure's PK study with Empli03 approved
» Sensidose's founder talks about the company's journey
Read BioStock's newsletter for v.36 here.
Morning news
Subscription price for the exercise of Cereno Scientifics warrants of series TO2 is set at SEK 1,9 per share. Read more.
PolarCool signs his first contract in the Finnish hockey league. Read more.
World Sepsis Day 2022 noticed by Aptahem. Read more.
Faron Pharmaceuticals shall present data regarding Traumakine of Military Health System Research Symposium (MHSRS) 2022. Read more.
MHSRS 2022 can also see Ilya Pharma present data for ILP100-Topical. Read more.
IRLAB will present at ABGSC Investor Day. Read more.
New agreement between Blekinge County and Ortivus respect MobiMed worth approximately SEK 4,5 million. Read more.
Spermosis adjusts the schedule for the production of JUNO-Checked System. Read more.
Oslo University Hospital shall include Integrums OPRA Implant System for artificial thumb prosthesis surgery. Read more.
SensoDetect informs the market about the current state of operations after the summer break. Read more.
Reports:
ScandiDos VibroSense
Change in the number of votes and equity:
Orion
Invitation to presentation:
Arctic Bioscience
Share buyback program:
Novo Nordisk Össur
News since Monday lunch
Ultimovacs has published phase I data regarding melanoma in Journal of Translational Medicine. Read more.
Hanna Sjöström, CEO of Neola., presents at ABG Sundal Colliers Investor Day on September 13. Read more.
Medivir will present at HC Wrainwright 2nd Annual Global Investment Conference 2022. Read more.
Pretzel Therapeutics has raised $72,5 million in Series A funding for groundbreaking treatments for mitochondrial diseases. Read more.
SMC recommend Hansa Biopharmas Idefirix for highly sensitized kidney transplant patients. Read more.
VitroLifes CEO retires and resigns from his position, the company announces. Read more.
Positive opinion for Pfizer and BioNTech's booster vaccine adapted for omicron BA.4/5. Read more.
Diabetes clinic in Germany evaluates VibroSense Meters II. Read more.
EQL Pharma has received an award from Apotek Hjärtat. Read more.
New study shows that Janssens Tremfya provides greater effect on plaque psoriasis when initiated early. Read more.
Novo Nordisk and Microsoft new collaboration is being entered into to accelerate drug discovery and development. Read more.
Medfield Diagnostics and FlexMed has written a "memorandum of understanding" regarding cooperation on distribution. Read more.
Real World Dataanalysis confirms safety and effectiveness with radium-223 dichloride followed by lutetium-177-PSMA for men with mCRPC, announces Bayer. Read more.
Bayer has also presented new data from ARASENS-study. Read more.
This morning's price development
Winner: Carbiotix 10,9%, Isofol Medical 10,9%, RhoVac 8,1%, Immunovia 6,7%, Vicore Pharma 6,4%
Förlorare: Cline Scientific -16,5%, Odinwell -12,3%, ScandiDos -12,0%, Chordate -11,9%, Calmark -8,8%
Index: OMXS30 1979 0,27%, Healthcare -0,15%
More articles from BioStock
» Pharmiva aims for highly valued global market
» Dr. Hoffmann presents results from Chordate's migraine study
» Pharmaceutical exports increasingly important for the Swedish economy
» BioInvent achieves milestone for BI-1808
» The election issues affecting the life science industry